Iqvia price target lowered to $255 from $269 at Stifel

Stifel lowered the firm’s price target on Iqvia to $255 from $269 and keeps a Buy rating on the shares. The firm believes trends in the business continue to be solid and the recent sell-off in the shares is unwarranted.